Author:
Perifanis Vassilios,Vyzantiadis Timoleon,Tziomalos Konstantinos,Vakalopoulou Sofia,Garipidou Vassilia,Athanassiou-Metaxa Miranda,Harsoulis Faidon
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference59 articles.
1. Alvarez L, Peris P, Guanabens N, Vidal S, Ros I, Pons F et al (2003) Serum osteoprotegerin and its ligand in Paget’s disease of bone: relationship to disease activity and effect of treatment with bisphosphonates. Arthritis Rheum 48:824–828
2. Arrighi H, Khosla S, Melton LJ, Riggs BL, Bekker PJ, Dunstan CR (2000) The relationship between circulating osteoprotegerin and estrogen in postmenopausal women. J Bone Miner Res 15(Suppl 1):S441
3. Body JJ, Lortholary A, Romieu G, Vigneron AM, Ford J (1999) A dose-finding study of zoledronate in hypercalcemic cancer patients. J Bone Miner Res 14:1557–1561
4. Browner WS, Lui LY, Cummings SR (2001) Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women. J Clin Endocrinol Metab 86:631–637
5. Cavallo L, Gurrado R, Gallo F, Zacchino C, De Mattia D, Tato L (1997) Growth deficiency in polytransfused beta-thalassaemia patients is not growth hormone dependent. Clin Endocrinol 46:701–706
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献